GlassScriptPhysician profile
Kearny Q Robert
NPI 1730117169
$1,214.14
in general payments reported to CMS, 2019-2025
22 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $171 · 2021: $178 · 2022: $147 · 2023: $291 · 2024: $200 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $262.67 | 2023-2024 | A/R Femoral Nail, Evo Retrograde, Distal Radius II |
| Stryker Corporation | $183.43 | 2019-2025 | Triathlon, Tornier Perform Reversed Glenoid |
| Depuy Synthes Sales INC. | $151.40 | 2020-2022 | |
| Organogenesis INC. | $71.73 | 2023-2024 | Puraply |
| Smith+Nephew, INC. | $65.52 | 2021 | |
| Fidia Pharma USA INC. | $63.23 | 2021 | |
| Pacira Therapeutics, INC. | $47.30 | 2019 | |
| Ethicon US, LLC | $39.95 | 2019-2025 | Ethicon |
| Ferring Pharmaceuticals INC. | $37.43 | 2022 | |
| Acera Surgical, INC. | $33.54 | 2025 | Restrata Wound Matrix |
| Convatec INC. | $29.42 | 2022 | |
| Bioventus LLC | $28.61 | 2020-2022 | |
| Baudax Bio INC. | $28.49 | 2020 | |
| Endo Pharmaceuticals INC. | $27.00 | 2020-2021 | |
| Kerecis Limited | $26.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.19 | 2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $20.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.15 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.65 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.38 | 2025 | |
| Esaote North America, INC. | $15.14 | 2025 | |
| Trevena, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kearny Robert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.